Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A00894 | Pages: 175 | Charts: 52 | Tables: 104 |
The Global MRI Systems Market Size was valued at $5,772.48 million in 2020, and is projected to reach $8,450.98 million by 2030, registering a CAGR of 3.9% from 2021 to 2030. Magnetic Resonance Imaging Systems uses a non-invasive imaging technology to investigate anatomy and function of the body in both aspects such as health and disease without the use of damaging ionizing radiation. It can be used in detection, diagnosis, and treatment monitoring of various chronic diseases. It is based on technology that excites and detects the changes occurred in protons found in the tissue fluid. It can differentiate between white matter and grey matter in the brain. It is the only imaging modality in demand as it does not use x-rays when frequent imaging is required for diagnosis or therapy, especially in the brain.
There are two types of MRI Systems available that include closed MRI and open MRI. Closed MRI Systems includes a large magnet and radio wave that sends signals and receives signals from the body. The open MRI Systems uses magnetic bottom & top and in this, all four sides are open reducing the risk of panic attacks and claustrophobia.
Get more information on this report : Request Sample Pages
The growth of the MRI Systems Market is driven by increase in geriatric population and rise in incidence of diseases such as brain tumor, breast cancer, prostate cancer, scoliosis, and sclerosis. Moreover, technological growth such as superconducting (SC) magnets, open architecture, high-field MRI, and software applications are other factors that contribute toward the growth of the market. However, decline in restitution rates for MRI procedures and scarcity of helium gas deposits are expected to hinder the growth of the market. Conversely, the advantage of MRI in detection of the early molecular and cellular changes in Alzheimer disease provides lucrative opportunities in the growth of the market.
Coronavirus (COVID-19) was discovered in late December, 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. The outbreak of COVID-19 pandemic has affected the MRI Systems Market, health facilities, their supply chain, and demand for MRI devices. However, the COVID-19 pandemic led to rise in the prices of MRI imaging, which resulted in increase in the prices of MRI Systems. Moreover, the delayed manufacturing, shipment, and payment of the MRI Systems players also affected the Magnetic Resonance Imaging Systems Market.
In addition, limited movement of people during the implementation of lockdown impacted the MRI Systems industry. Overall, the impact of COVID-19 on the MRI Systems Market was recorded to be fairly negative. This was attributed to disturbances in production, import & export of raw material and finished goods and increase in the demand and supply gap due to shutdowns in various COVID-19 affected countries, and large number of workers falling ill during the pandemic. However, this situation is expected to change post COVID-19 pandemic in the coming years.
The MRI Systems Market is segmented on the basis of architecture type, field strength, and region. On the basis of architecture type, it is bifurcated into open MRI and closed MRI Systems. On the basis of field strength, it is classified into low-field Systems, high-field Systems, and medium-field Systems. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By architecture type, the market is categorized into open MRI and closed MRI Systems. The closed MRI Systems segment dominates the global MRI Systems Market in 2020, and is anticipated to continue this trend during the forecast period owing to key factors such as advantages of using closed MRI Systems over open MRI Systems, rise in demand for closed MRI Systems, surge in prevalence of chronic diseases, advancements in the MRI Systems, and the launch of new products.
[ARCHITECTURETYPEGRAPH]
By field strength, the Magnetic Resonance Imaging Systems Market is segregated into low-field Systems, high-field Systems, and medium-field Systems. The medium-field Systems segment accounted for the majority of market share in the 2020 owing to rise in prevalence of chronic diseases in both developed as well as developing countries, rise in demand for medical imaging, increase in government initiatives, and surge in the adoption of medium-field MRI Systems in the hospitals & healthcare centers.
[FIELDSTRENTHGRAPH]
North America accounted for major share of the global MRI Systems Market in 2020, and is expected to remain dominant throughout the forecast period. This was attributed to increase in number of chronic disease patients, rise in spread of hospitals awareness toward adoption of MRI Systems, surge in demand for MRI Systems, availability of advanced healthcare facilities with trained medical professionals, presence of most of the key players, and surge in investment made by governments in the healthcare Systems. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.
[REGIONGRAPH]
Key benefits for stakeholders
Key Market Segments
CHAPTER 1: INTRODUCTION
1.1.Report Description
1.2.Key Market Segments
1.3.Key Benefits
1.4.Research Methodology
1.4.1.Primary Research
1.4.2.Secondary Research
1.4.3.Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1.Market Definition and Scope
3.2.Key Findings
3.2.1.Top Investment Pockets
3.2.2.Top Winning Strategies
3.3.Porter's Five Forces Analysis
3.3.1.Bargaining Power of Suppliers
3.3.2.Threat of New Entrants
3.3.3.Threat of Substitutes
3.3.4.Competitive Rivalry
3.3.5.Bargaining Power among Buyers
3.4.Market Share Analysis/Top Player Positioning
3.4.1.Market Share Analysis/Top Player Positioning 2020
3.5.Market Dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6. COVID-19 Impact Analysis
CHAPTER 4: MRI SYSTEMS MARKET, BY ARCHITECTURE TYPE
4.1.Market Overview
4.1.1Market Size and Forecast, By Architecture Type
4.2.Open MRI System
4.2.1.Key Market Trends, Growth Factors and Opportunities
4.2.2.Market Size and Forecast, By Region
4.2.3.Market Share Analysis, By Country
4.3.Closed MRI System
4.3.1.Key Market Trends, Growth Factors and Opportunities
4.3.2.Market Size and Forecast, By Region
4.3.3.Market Share Analysis, By Country
CHAPTER 5: MRI SYSTEMS MARKET, BY FIELD STRENGTH
5.1.Market Overview
5.1.1Market Size and Forecast, By Field Strength
5.2.Low-field System
5.2.1.Key Market Trends, Growth Factors and Opportunities
5.2.2.Market Size and Forecast, By Region
5.2.3.Market Share Analysis, By Country
5.3.High-field System
5.3.1.Key Market Trends, Growth Factors and Opportunities
5.3.2.Market Size and Forecast, By Region
5.3.3.Market Share Analysis, By Country
5.4.Medium-field System
5.4.1.Key Market Trends, Growth Factors and Opportunities
5.4.2.Market Size and Forecast, By Region
5.4.3.Market Share Analysis, By Country
CHAPTER 6: MRI SYSTEMS MARKET, BY REGION
6.1.Market Overview
6.1.1Market Size and Forecast, By Region
6.2.North America
6.2.1.Key Market Trends and Opportunities
6.2.2.Market Size and Forecast, By Architecture Type
6.2.3.Market Size and Forecast, By Field Strength
6.2.4.Market Size and Forecast, By Country
6.2.5.United States Mri System Market
6.2.5.1.Market Size and Forecast, By Architecture Type
6.2.5.2.Market Size and Forecast, By Field Strength
6.2.6.Canada Mri System Market
6.2.6.1.Market Size and Forecast, By Architecture Type
6.2.6.2.Market Size and Forecast, By Field Strength
6.2.7.Mexico Mri System Market
6.2.7.1.Market Size and Forecast, By Architecture Type
6.2.7.2.Market Size and Forecast, By Field Strength
6.3.Europe
6.3.1.Key Market Trends and Opportunities
6.3.2.Market Size and Forecast, By Architecture Type
6.3.3.Market Size and Forecast, By Field Strength
6.3.4.Market Size and Forecast, By Country
6.3.5.France Mri System Market
6.3.5.1.Market Size and Forecast, By Architecture Type
6.3.5.2.Market Size and Forecast, By Field Strength
6.3.6.Germany Mri System Market
6.3.6.1.Market Size and Forecast, By Architecture Type
6.3.6.2.Market Size and Forecast, By Field Strength
6.3.7.Italy Mri System Market
6.3.7.1.Market Size and Forecast, By Architecture Type
6.3.7.2.Market Size and Forecast, By Field Strength
6.3.8.Spain Mri System Market
6.3.8.1.Market Size and Forecast, By Architecture Type
6.3.8.2.Market Size and Forecast, By Field Strength
6.3.9.U.K Mri System Market
6.3.9.1.Market Size and Forecast, By Architecture Type
6.3.9.2.Market Size and Forecast, By Field Strength
6.3.10.Rest Of Europe Mri System Market
6.3.10.1.Market Size and Forecast, By Architecture Type
6.3.10.2.Market Size and Forecast, By Field Strength
6.4.Asia-Pacific
6.4.1.Key Market Trends and Opportunities
6.4.2.Market Size and Forecast, By Architecture Type
6.4.3.Market Size and Forecast, By Field Strength
6.4.4.Market Size and Forecast, By Country
6.4.5.China Mri System Market
6.4.5.1.Market Size and Forecast, By Architecture Type
6.4.5.2.Market Size and Forecast, By Field Strength
6.4.6.Japan Mri System Market
6.4.6.1.Market Size and Forecast, By Architecture Type
6.4.6.2.Market Size and Forecast, By Field Strength
6.4.7.India Mri System Market
6.4.7.1.Market Size and Forecast, By Architecture Type
6.4.7.2.Market Size and Forecast, By Field Strength
6.4.8.South Korea Mri System Market
6.4.8.1.Market Size and Forecast, By Architecture Type
6.4.8.2.Market Size and Forecast, By Field Strength
6.4.9.Australia Mri System Market
6.4.9.1.Market Size and Forecast, By Architecture Type
6.4.9.2.Market Size and Forecast, By Field Strength
6.4.10.Rest of Asia Pacific Mri System Market
6.4.10.1.Market Size and Forecast, By Architecture Type
6.4.10.2.Market Size and Forecast, By Field Strength
6.5.LAMEA
6.5.1.Key Market Trends and Opportunities
6.5.2.Market Size and Forecast, By Architecture Type
6.5.3.Market Size and Forecast, By Field Strength
6.5.4.Market Size and Forecast, By Country
6.5.5.Brazil Mri System Market
6.5.5.1.Market Size and Forecast, By Architecture Type
6.5.5.2.Market Size and Forecast, By Field Strength
6.5.6.South Africa, Mri System Market
6.5.6.1.Market Size and Forecast, By Architecture Type
6.5.6.2.Market Size and Forecast, By Field Strength
6.5.7.Saudi Arabia Mri System Market
6.5.7.1.Market Size and Forecast, By Architecture Type
6.5.7.2.Market Size and Forecast, By Field Strength
6.5.8.Rest of LAMEA Mri System Market
6.5.8.1.Market Size and Forecast, By Architecture Type
6.5.8.2.Market Size and Forecast, By Field Strength
CHAPTER 7: COMPANY PROFILES
7.1.Barco N.V.
7.1.1.Company Overview
7.1.2.Key Executives
7.1.3.Company snapshot
7.1.4.Operating business segments
7.1.5.Product portfolio
7.1.6.Business Performance
7.1.7.Key Strategic Moves and Developments
7.2.General Electric Company (GE Healthcare)
7.2.1.Company Overview
7.2.2.Key Executives
7.2.3.Company snapshot
7.2.4.Operating business segments
7.2.5.Product portfolio
7.2.6.Business Performance
7.2.7.Key Strategic Moves and Developments
7.3.Hitachi, Ltd. (Hitachi Medical Corporation)
7.3.1.Company Overview
7.3.2.Key Executives
7.3.3.Company snapshot
7.3.4.Operating business segments
7.3.5.Product portfolio
7.3.6.Business Performance
7.3.7.Key Strategic Moves and Developments
7.4.Hologic Inc.
7.4.1.Company Overview
7.4.2.Key Executives
7.4.3.Company snapshot
7.4.4.Operating business segments
7.4.5.Product portfolio
7.4.6.Business Performance
7.4.7.Key Strategic Moves and Developments
7.5.Koninklijke Philips N.V.
7.5.1.Company Overview
7.5.2.Key Executives
7.5.3.Company snapshot
7.5.4.Operating business segments
7.5.5.Product portfolio
7.5.6.Business Performance
7.5.7.Key Strategic Moves and Developments
7.6.Nordion Inc.
7.6.1.Company Overview
7.6.2.Key Executives
7.6.3.Company snapshot
7.6.4.Operating business segments
7.6.5.Product portfolio
7.6.6.Business Performance
7.6.7.Key Strategic Moves and Developments
7.7.Onex Corporation (Carestream Health)
7.7.1.Company Overview
7.7.2.Key Executives
7.7.3.Company snapshot
7.7.4.Operating business segments
7.7.5.Product portfolio
7.7.6.Business Performance
7.7.7.Key Strategic Moves and Developments
7.8.Shimadzu Corporation
7.8.1.Company Overview
7.8.2.Key Executives
7.8.3.Company snapshot
7.8.4.Operating business segments
7.8.5.Product portfolio
7.8.6.Business Performance
7.8.7.Key Strategic Moves and Developments
7.9.Siemens AG (Siemens Healthcare)
7.9.1.Company Overview
7.9.2.Key Executives
7.9.3.Company snapshot
7.9.4.Operating business segments
7.9.5.Product portfolio
7.9.6.Business Performance
7.9.7.Key Strategic Moves and Developments
7.10.Toshiba Corporation (Toshiba Medical Systems Corporation)
7.10.1.Company Overview
7.10.2.Key Executives
7.10.3.Company snapshot
7.10.4.Operating business segments
7.10.5.Product portfolio
7.10.6.Business Performance
7.10.7.Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1.GLOBAL MRI SYSTEMS MARKET, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 2.GLOBAL MRI SYSTEMS MARKET FOR OPEN MRI SYSTEM, BY REGION, 2020-2030 ($MILLION)
TABLE 3.GLOBAL MRI SYSTEMS MARKET FOR CLOSED MRI SYSTEM, BY REGION, 2020-2030 ($MILLION)
TABLE 4.GLOBAL MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 5.GLOBAL MRI SYSTEMS MARKET FOR LOW-FIELD SYSTEM, BY REGION, 2020-2030 ($MILLION)
TABLE 6.GLOBAL MRI SYSTEMS MARKET FOR HIGH-FIELD SYSTEM, BY REGION, 2020-2030 ($MILLION)
TABLE 7.GLOBAL MRI SYSTEMS MARKET FOR MEDIUM-FIELD SYSTEM, BY REGION, 2020-2030 ($MILLION)
TABLE 8.GLOBAL MRI SYSTEMS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 9.NORTH AMERICA MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 10.NORTH AMERICA MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 11.UNITED STATES MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 12.UNITED STATES MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 13.CANADA MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 14.CANADA MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 15.MEXICO MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 16.MEXICO MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 17.EUROPE MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 18.EUROPE MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 19.FRANCE MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 20.FRANCE MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 21.GERMANY MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 22.GERMANY MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 23.ITALY MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 24.ITALY MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 25.SPAIN MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 26.SPAIN MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 27.UNITED KINGDOM MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 28.UNITED KINGDOM MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 29.REST OF EUROPE MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 30.REST OF EUROPE MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 31.ASIA-PACIFIC MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 32.ASIA-PACIFIC MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 33.CHINA MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 34.CHINA MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 35.JAPAN MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 36.JAPAN MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 37.INDIA MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 38.INDIA MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 39.SOUTH KOREA MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 40.SOUTH KOREA MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 41.AUSTRALIA MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 42.AUSTRALIA MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 43.REST OF ASIA PACIFIC MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 44.REST OF ASIA PACIFIC MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 45.LAMEA MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 46.LAMEA MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 47.BRAZIL MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 48.BRAZIL MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 49.SOUTH AFRICA, MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 50.SOUTH AFRICA, MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 51.SAUDI ARABIA MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 52.SAUDI ARABIA MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 53.REST OF LAMEA MRI SYSTEM, BY ARCHITECTURE TYPE, 2020-2030 ($MILLION)
TABLE 54.REST OF LAMEA MRI SYSTEM, BY FIELD STRENGTH, 2020-2030 ($MILLION)
TABLE 55.BARCO N.V.: KEY EXECUTIVES
TABLE 56.BARCO N.V.: COMPANY SNAPSHOT
TABLE 57.BARCO N.V.: OPERATING SEGMENTS
TABLE 58.BARCO N.V.: PRODUCT PORTFOLIO
TABLE 59.BARCO N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 60.GENERAL ELECTRIC COMPANY (GE HEALTHCARE): KEY EXECUTIVES
TABLE 61.GENERAL ELECTRIC COMPANY (GE HEALTHCARE): COMPANY SNAPSHOT
TABLE 62.GENERAL ELECTRIC COMPANY (GE HEALTHCARE): OPERATING SEGMENTS
TABLE 63.GENERAL ELECTRIC COMPANY (GE HEALTHCARE): PRODUCT PORTFOLIO
TABLE 64.GENERAL ELECTRIC COMPANY (GE HEALTHCARE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 65.HITACHI, LTD. (HITACHI MEDICAL CORPORATION): KEY EXECUTIVES
TABLE 66.HITACHI, LTD. (HITACHI MEDICAL CORPORATION): COMPANY SNAPSHOT
TABLE 67.HITACHI, LTD. (HITACHI MEDICAL CORPORATION): OPERATING SEGMENTS
TABLE 68.HITACHI, LTD. (HITACHI MEDICAL CORPORATION): PRODUCT PORTFOLIO
TABLE 69.HITACHI, LTD. (HITACHI MEDICAL CORPORATION): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 70.HOLOGIC INC.: KEY EXECUTIVES
TABLE 71.HOLOGIC INC.: COMPANY SNAPSHOT
TABLE 72.HOLOGIC INC.: OPERATING SEGMENTS
TABLE 73.HOLOGIC INC.: PRODUCT PORTFOLIO
TABLE 74.HOLOGIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75.KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 76.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 77.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 78.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 79.KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 80.NORDION INC.: KEY EXECUTIVES
TABLE 81.NORDION INC.: COMPANY SNAPSHOT
TABLE 82.NORDION INC.: OPERATING SEGMENTS
TABLE 83.NORDION INC.: PRODUCT PORTFOLIO
TABLE 84.NORDION INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 85.ONEX CORPORATION (CARESTREAM HEALTH): KEY EXECUTIVES
TABLE 86.ONEX CORPORATION (CARESTREAM HEALTH): COMPANY SNAPSHOT
TABLE 87.ONEX CORPORATION (CARESTREAM HEALTH): OPERATING SEGMENTS
TABLE 88.ONEX CORPORATION (CARESTREAM HEALTH): PRODUCT PORTFOLIO
TABLE 89.ONEX CORPORATION (CARESTREAM HEALTH): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90.SHIMADZU CORPORATION: KEY EXECUTIVES
TABLE 91.SHIMADZU CORPORATION: COMPANY SNAPSHOT
TABLE 92.SHIMADZU CORPORATION: OPERATING SEGMENTS
TABLE 93.SHIMADZU CORPORATION: PRODUCT PORTFOLIO
TABLE 94.SHIMADZU CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95.SIEMENS AG (SIEMENS HEALTHCARE): KEY EXECUTIVES
TABLE 96.SIEMENS AG (SIEMENS HEALTHCARE): COMPANY SNAPSHOT
TABLE 97.SIEMENS AG (SIEMENS HEALTHCARE): OPERATING SEGMENTS
TABLE 98.SIEMENS AG (SIEMENS HEALTHCARE): PRODUCT PORTFOLIO
TABLE 99.SIEMENS AG (SIEMENS HEALTHCARE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.TOSHIBA CORPORATION (TOSHIBA MEDICAL SYSTEMS CORPORATION): KEY EXECUTIVES
TABLE 101.TOSHIBA CORPORATION (TOSHIBA MEDICAL SYSTEMS CORPORATION): COMPANY SNAPSHOT
TABLE 102.TOSHIBA CORPORATION (TOSHIBA MEDICAL SYSTEMS CORPORATION): OPERATING SEGMENTS
TABLE 103.TOSHIBA CORPORATION (TOSHIBA MEDICAL SYSTEMS CORPORATION): PRODUCT PORTFOLIO
TABLE 104.TOSHIBA CORPORATION (TOSHIBA MEDICAL SYSTEMS CORPORATION): KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1.GLOBAL MRI SYSTEMS MARKET SEGMENTATION
FIGURE 2.GLOBAL MRI SYSTEMS MARKET
FIGURE 3.SEGMENTATION MRI SYSTEMS MARKET
FIGURE 4.TOP INVESTMENT POCKET IN MRI SYSTEMS MARKET
FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
FIGURE 11.LOW THREAT OF SUBSTITUTION
FIGURE 12.HIGH COMPETITIVE RIVALRY
FIGURE 13.TOP PLAYER POSITIONING, 2020
FIGURE 14.MARKET SHARE ANALYSIS, 2020
FIGURE 15.RESTRAINTS AND DRIVERS: MRI SYSTEM MARKET
FIGURE 16.MRI SYSTEMS MARKET SEGMENTATION, BY ARCHITECTURE TYPE
FIGURE 17.MRI SYSTEMS MARKET FOR OPEN MRI SYSTEM, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 18.MRI SYSTEMS MARKET FOR CLOSED MRI SYSTEM, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 19.MRI SYSTEMS MARKET SEGMENTATION, BY FIELD STRENGTH
FIGURE 20.MRI SYSTEMS MARKET FOR LOW-FIELD SYSTEM, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 21.MRI SYSTEMS MARKET FOR HIGH-FIELD SYSTEM, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 22.MRI SYSTEMS MARKET FOR MEDIUM-FIELD SYSTEM, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 23.BARCO N.V.: NET SALES, 2018-2020 ($MILLION)
FIGURE 24.BARCO N.V.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 25.BARCO N.V.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 26.GENERAL ELECTRIC COMPANY (GE HEALTHCARE): NET SALES, 2018-2020 ($MILLION)
FIGURE 27.GENERAL ELECTRIC COMPANY (GE HEALTHCARE): REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 28.GENERAL ELECTRIC COMPANY (GE HEALTHCARE): REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 29.HITACHI, LTD. (HITACHI MEDICAL CORPORATION): NET SALES, 2018-2020 ($MILLION)
FIGURE 30.HITACHI, LTD. (HITACHI MEDICAL CORPORATION): REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 31.HITACHI, LTD. (HITACHI MEDICAL CORPORATION): REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 32.HOLOGIC INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 33.HOLOGIC INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 34.HOLOGIC INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 35.KONINKLIJKE PHILIPS N.V.: NET SALES, 2018-2020 ($MILLION)
FIGURE 36.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 37.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 38.NORDION INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 39.NORDION INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 40.NORDION INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 41.ONEX CORPORATION (CARESTREAM HEALTH): NET SALES, 2018-2020 ($MILLION)
FIGURE 42.ONEX CORPORATION (CARESTREAM HEALTH): REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 43.ONEX CORPORATION (CARESTREAM HEALTH): REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 44.SHIMADZU CORPORATION: NET SALES, 2018-2020 ($MILLION)
FIGURE 45.SHIMADZU CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 46.SHIMADZU CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 47.SIEMENS AG (SIEMENS HEALTHCARE): NET SALES, 2018-2020 ($MILLION)
FIGURE 48.SIEMENS AG (SIEMENS HEALTHCARE): REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 49.SIEMENS AG (SIEMENS HEALTHCARE): REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 50.TOSHIBA CORPORATION (TOSHIBA MEDICAL SYSTEMS CORPORATION): NET SALES, 2018-2020 ($MILLION)
FIGURE 51.TOSHIBA CORPORATION (TOSHIBA MEDICAL SYSTEMS CORPORATION): REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 52.TOSHIBA CORPORATION (TOSHIBA MEDICAL SYSTEMS CORPORATION): REVENUE SHARE, BY REGION, 2020 (%)